Navigation Links
Quanterix Fifth-Generation PSA Test Enables More Sensitive Measurements Following Surgery
Date:11/2/2011

CEO of Quanterix.  

About Quanterix

Quanterix Corporation is developing its proprietary Single Molecule Array (SiMoA™) technology for the in vitro diagnostics and life science research markets. The digital nature of SiMoA yields unprecedented assay performance, stemming from a 1,000-fold improvement in sensitivity compared with today's analog only technology. SiMoA will enable researchers in life science to validate novel, low abundance biomolecules from a single droplet of blood, leading to greater insight into disease detection, diagnosis, therapy selection and disease monitoring. Automated systems based on SiMoA will provide diagnostic test information to healthcare practitioners faster, with greater reliability, unprecedented range and increased cost effectiveness.  Founded in 2007, the privately held Cambridge, Massachusetts-based company is backed by leading life science investors including ARCH Venture Partners, Bain Capital Ventures, and Flagship Ventures. For additional information, please visit www.quanterix.com.


'/>"/>
SOURCE Quanterix Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Quanterix PSA Test Found to be a Reliable Predictor of Prostate Cancer Recurrence Following Surgery
2. Quanterix Digital ELISA Measures Low Abundance Biomarkers of Inflammation in Crohns Disease
3. Quanterix and STRATEC Announce Strategic Partnership
4. Quanterix Announces Publication of Novel Method Expanding Single Molecule Detection Capability
5. Quanterix Announces New Technology Evaluation Agreement
6. Quanterix Corporation Announces the Addition of Dr. Robert Corn to its Scientific Advisory Board
7. Life Technologies Announces Flagship PCR Instrument that Enables Cost-Effective, High-Throughput Screening Applications
8. Clinical Integration Enables Leading Health Systems to Deliver Higher Quality, Cost-Effective Care
9. Agreement Between SomaLogic and New England Biolabs Enables the Use of SOMAmer Technology for the Optimization of Multiple PCR Products
10. Molecular Devices Enables Intuitive Functionality at Your Fingertips on the Apple iPad with the Latest SoftMax Pro Software
11. Life Technologies Signs Exclusive License Agreement for TAL Effector Technology That Enables Synthetic Biologists to Precisely Control Gene Expression in Engineered Organisms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2015   Hospira, Inc. (NYSE: HSP ... its partner, Celltrion – a global biopharmaceutical company – has ... Agency in Brazil – for ... use in Brazil . The medication ... sells biosimilar infliximab in 26 European countries and in ...
(Date:6/2/2015)... June 02, 2015 “Stem Cell Therapy to ... mainstream, and it is used often as an adjunct to ... practitioners are not yet aware or comfortable enough with the ... is most often reserved for the last resort cases - ... can barely lift a paw to get around. It is ...
(Date:6/2/2015)... 2015   Intrexon Corporation (NYSE: ... today the appointment of Olivier R. Jarry ... Mr. Jarry will lead the expansion of Intrexon,s programs ... for consumer markets.  Mr. Jarry ... in leading global life sciences and consumer health ...
(Date:6/2/2015)... , June 2, 2015  RXi ... biotechnology company focused on discovering and developing ... dermatology and ophthalmology, today announced that Dr. ... will present at the 23 rd ... world congress will include in-depth presentations by ...
Breaking Biology Technology:ANVISA Approves First Infliximab Biosimilar in Brazil 2ANVISA Approves First Infliximab Biosimilar in Brazil 3ANVISA Approves First Infliximab Biosimilar in Brazil 4ANVISA Approves First Infliximab Biosimilar in Brazil 5VetStem Biopharma, Proudly Announces a New Long Term Partnership with VCA West Los Angeles in Support of Stem Cell Therapy Training and Clinical Opportunities. 2VetStem Biopharma, Proudly Announces a New Long Term Partnership with VCA West Los Angeles in Support of Stem Cell Therapy Training and Clinical Opportunities. 3Intrexon Announces New Sector Leader 2Intrexon Announces New Sector Leader 3RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 3RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 4
... DIEGO, Nov. 11 Accumetrics, Inc. has announced the,appointment ... for the company.,Dr. Young will serve in a part-time ... Medicine and Director of the Cardiovascular,Innovations Program at The ... as the main liaison to practicing clinicians, as well ...
... Accera, Inc., a,biotechnology company delivering breakthrough therapies in ... a Series C financing,round of $35 million (euro ... of this financing will be used to begin ... (previously known as Ketasyn), which,is scheduled to launch ...
... Enterprises, LLC (, http://www.CJPS-Enterprises.com ) announced that ... its services to leverage companies, intellectual property (IP) ... value of their intangible assets.,This customized service is ... is a firm that specializes in growing,companies in ...
Cached Biology Technology:Accumetrics Appoints John J. Young, MD Chief Medical Officer 2Accera, Inc. Completes $35 Million Series C Financing 2CJPS Enterprises Provides New Strategies To Create Additional Revenues for Companies with Intellectual Property 2
(Date:6/1/2015)... -- According to a new market research ... (Touch-based & Touchless), Application (Consumer Electronics, Automotive, & Others), ... Global Forecast to 2020", published by MarketsandMarkets, the Gesture ... $23.55 Billion by 2020, at a CAGR of 28.23% ... market data T ables and   86   ...
(Date:6/1/2015)... , June 1, 2015 ... Generation Biometrics Market by Application (Government, Military & ... & Immigration, and Security), Technology (Face Recognition, Fingerprint ... Recognition, Vein Recognition, and Others), Function (Contact and ... , Europe , APAC, Row) ...
(Date:5/29/2015)... DUBLIN , May 28, 2015 ... the addition of the "Facial Recognition Market ... User - Global Forecast to 2020" report ... years, have seen facial recognition technology become more ... technology to gain traction and investment from the ...
Breaking Biology News(10 mins):Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 2Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 3Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 4Next Generation Biometrics Market Worth $24,448.84 Million by 2020 2Next Generation Biometrics Market Worth $24,448.84 Million by 2020 3Next Generation Biometrics Market Worth $24,448.84 Million by 2020 4Global advanced Facial Recognition Market Expected to Grow From $2.77 Billion in 2015 to $6.19 Billion in 2020, at an Estimated CAGR of 17.4% 2
... in women is highly recognized by the public. Less appreciated is ... million males have been diagnosed with osteoporosis and another three million ... thought to be major factors behind bone fractures in both sexes. ... levels of the testosterone are known to be at risk. Low ...
... of Public Health researchers have found that older adolescents ... engage in healthy activities such as exercising, eating fruits ... larger quantities of sweetened beverages and fast food, were ... less than teens without TVs in their bedrooms. ...
... Simple environmental enrichment and increased social stress can both ... new monkey research at Wake Forest University School of ... shown that social rank whether animals are dominant ... the amount of cocaine that monkeys will self-administer. Housed ...
Cached Biology News:Testosterone replacement theraphy beneficial in men 60 and older 2Testosterone replacement theraphy beneficial in men 60 and older 3U of M research finds teens who have TV in their bedroom are less likely to engage in healthy habits 2Environmental enrichment can reduce cocaine use, researchers find 2
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (C6921) ... assistance. Mfr Desig: Corning ...
A cost-effective serum for general cell growth requirements. All serum is collected from calves aged 10 days old or less....
... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
... culture scale-up, these culture chambers produce cell ... 9 range and are useful alternatives ... • High mechanical • strength and structural ... shipping • Certified nonpyrogenic and sterilized by ...
Biology Products: